Lavanya Rajagopal1, Shivashekar Ganapathy2, Sundaram Arunachalam3, Veena Raja1, Balaji Ramraj4. 1. Assistant Professor, Department of Pathology, SRM Medical College Hospital and Research Centre , Chennai, Tamilnadu, India . 2. Professor and Head, Department of Pathology, SRM Medical College Hospital and Research Centre , Chennai, Tamilnadu, India . 3. Professor (Dean Medical), Department of Pathology, SRM Medical College Hospital and Research Centre , Chennai, Tamilnadu, India . 4. Assistant Professor, Department of Community Medicine, SRM Medical College Hospital and Research Centre , Chennai, Tamilnadu, India .
Abstract
INTRODUCTION: Anaemia has a high prevalence having great impact worldwide and potentially contributing to the pathogenesis of various chronic diseases. Approximately 1/3rd of patients with anaemia have iron deficiency. American Diabetes Association (ADA) has affirmed Glycated Haemoglobin (HbA1C) ≥ 6.5% as a diagnostic criterion for Diabetes Mellitus (DM). Variation of HbA1C in Iron Deficiency Anaemia (IDA) has clashing results. AIM: To decide the impact of IDA on HbA1C levels among non diabetics. To assess and analyse the variation of HbA1C according to the degree of anaemia (mild, moderate and severe). MATERIALS AND METHODS: This cross-sectional study was carried out in SRM Medical College Hospital and Research Centre, Chennai, Tamil Nadu from February 2016 to October 2016 and approved by our Institutional Ethical Committee. Totally 150 non diabetics (75 with IDA and 75 without IDA) were included in this study. Medical history was recorded and HbA1C, Haemoglobin (Hb), Haematocrit (Hct), red cell indices, serum iron, ferritin and Fasting Plasma Glucose (FPG) were tested. RESULTS: The IDA patients in this study had a mean HbA1C (6.84±0.07%) which was higher than the non anaemic group (5.12±0.04%) and this difference was statistically significant (p< 0.05). HbA1C level was increased when severity of anaemia worsened. Also, noteworthy statistical significance was observed between no anaemia, mild, moderate and severe anaemia (p< 0.05). CONCLUSION: In this study, we observed a positive correlation between IDA and elevated HbA1C level in non-diabetic population.
INTRODUCTION:Anaemia has a high prevalence having great impact worldwide and potentially contributing to the pathogenesis of various chronic diseases. Approximately 1/3rd of patients with anaemia have iron deficiency. American Diabetes Association (ADA) has affirmed Glycated Haemoglobin (HbA1C) ≥ 6.5% as a diagnostic criterion for Diabetes Mellitus (DM). Variation of HbA1C in Iron Deficiency Anaemia (IDA) has clashing results. AIM: To decide the impact of IDA on HbA1C levels among non diabetics. To assess and analyse the variation of HbA1C according to the degree of anaemia (mild, moderate and severe). MATERIALS AND METHODS: This cross-sectional study was carried out in SRM Medical College Hospital and Research Centre, Chennai, Tamil Nadu from February 2016 to October 2016 and approved by our Institutional Ethical Committee. Totally 150 non diabetics (75 with IDA and 75 without IDA) were included in this study. Medical history was recorded and HbA1C, Haemoglobin (Hb), Haematocrit (Hct), red cell indices, serum iron, ferritin and Fasting Plasma Glucose (FPG) were tested. RESULTS: The IDA patients in this study had a mean HbA1C (6.84±0.07%) which was higher than the non anaemic group (5.12±0.04%) and this difference was statistically significant (p< 0.05). HbA1C level was increased when severity of anaemia worsened. Also, noteworthy statistical significance was observed between no anaemia, mild, moderate and severe anaemia (p< 0.05). CONCLUSION: In this study, we observed a positive correlation between IDA and elevated HbA1C level in non-diabetic population.
Entities:
Keywords:
Degree of anemia; Glycated hemoglobin; Iron status
Authors: Emma English; Iskandar Idris; Georgina Smith; Ketan Dhatariya; Eric S Kilpatrick; W Garry John Journal: Diabetologia Date: 2015-05-21 Impact factor: 10.122
Authors: Christopher D Saudek; William H Herman; David B Sacks; Richard M Bergenstal; David Edelman; Mayer B Davidson Journal: J Clin Endocrinol Metab Date: 2008-05-06 Impact factor: 5.958
Authors: Mayra L Estrella; Cynthia M Pérez; Erick Suárez; Wilmarie Fuentes-Payán; Bharat Thyagarajan; Jonathan C Goldsmith; Martha L Daviglus; M Larissa Avilés-Santa Journal: Endocr Pract Date: 2021-12-08 Impact factor: 3.443
Authors: Christoph Schindler; Andreas L Birkenfeld; Markolf Hanefeld; Ulrike Schatz; Carsta Köhler; Martin Grüneberg; Diethelm Tschöpe; Matthias Blüher; Christoph Hasslacher; Stefan R Bornstein Journal: Diabetes Ther Date: 2017-11-13 Impact factor: 2.945